SCHEMBL2663535

SCHEMBL2663535

C[C@H](NN)c1ccc(C=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 1/20 0.59
▸ ALDH1A3 P47895 2/20 0.44
▸ CYP2A6 P11509 4/20 0.43
▸ GRIA4 P48058 1/20 0.41
▸ ALDH1A1 P00352 7/20 0.39
▸ CYP2A13 Q16696 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.38
▸ ALDH5A1 P51649 1/20 0.38
▸ ABAT P80404 1/20 0.38
▸ ALDH3A1 P30838 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.34
▸ STS P08842 1/20 0.34
▸ AKR1C3 P42330 1/20 0.34
▸ AKR1C2 P52895 1/20 0.34
▸ MMP1 P03956 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ MMP3 P08254 1/20 0.33
▸ MMP7 P09237 1/20 0.33
▸ MMP9 P14780 1/20 0.33
▸ MMP13 P45452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13175286 1.00 TYR (0.59) TYRALDH1A3CYP2A6GRIA4ALDH1A1
SCHEMBL25687911 0.81 TYR (0.61) TYRALDH1A3CYP2A6GRIA4ALDH1A1
SCHEMBL20324104 0.81 TYR (0.61) TYRALDH1A3CYP2A6GRIA4ALDH1A1
SCHEMBL2662574 0.76 TYR (0.55) TYRALDH1A3CYP2A6GRIA4ALDH1A1
SCHEMBL13655918 0.76 TYR (0.67) TYRALDH1A3CYP2A6GRIA4ALDH1A1
SCHEMBL12931759 0.76 TYR (0.67) TYRALDH1A3CYP2A6GRIA4ALDH1A1
SCHEMBL13954354 0.76 TYR (0.67) TYRALDH1A3CYP2A6GRIA4ALDH1A1
SCHEMBL7802093 0.75 TYR (0.73) TYRALDH1A3CYP2A6GRIA4ALDH1A1
Cuminaldehyde SCHEMBL87226 0.75 TYR (1.00) TYRALDH1A3CYP2A6ALDH1A1CYP2A13
Cuminaldehyde SCHEMBL719761 0.75 TYR (1.00) TYRALDH1A3CYP2A6ALDH1A1CYP2A13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625938-B2 Substituted pyrazoles, compositions containing such compounds and methods of use MERCK & CO., INC. (US) 2009-12-01 — — US disclosed
US-20080108620-A1 Substituted Pyrazoles, Compositions Containing such Compounds and Methods of Use MERCK & CO., INC. (US) 2008-05-08 — — US disclosed
US-20070088070-A1 Pyrazole derivatives, compositions containing such compounds and methods of use PARMEE EMMA R 2007-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088070-A1 Pyrazole derivatives, compositions containing such compounds and methods of use PC, GOT2, PNLIP TYR 387/4885ALDH1A3 1105/4885CYP2A6 441/4885
US-20080108620-A1 Substituted Pyrazoles, Compositions Containing such Compounds and Methods of Use GLP1R, GCGR, GPR119 TYR 688/4885ALDH1A3 2245/4885CYP2A6 861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback